Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,074,808
+$25,104,322 QoQ
Shares Held
2,646,201
+39.6% QoQ
Ownership
4.55%
of shares outstanding
% of Portfolio
3.41%
of 13F equity value
Holder Rank
#4
of 331 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $319,058,775 across 7 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (38.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
2,646,201 | $123,074,808 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
535,838 | $90,310,136 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
13,932,000 | $58,653,720 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
336,000 | $15,882,720 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,958,702 | $15,512,919 | |
| 6 | EOLS |
Evolus, Inc.
|
1,436,000 | $9,965,840 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
8,705,589 | $5,658,632 |
All Filings in SUPN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,074,808 | 2,646,201 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $97,970,486 | 1,895,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $137,370,800 | 2,764,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $135,532,440 | 2,836,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $151,674,240 | 4,812,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $170,169,000 | 5,196,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $174,869,760 | 4,836,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $158,893,280 | 5,096,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $141,026,000 | 5,272,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $121,840,920 | 3,572,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $134,571,000 | 4,650,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $140,386,440 | 5,092,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $151,382,160 | 5,036,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $157,600,500 | 4,350,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $155,378,520 | 4,356,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $155,473,185 | 4,593,004 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $136,271,040 | 4,712,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $100,192,000 | 3,100,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $120,605,760 | 4,136,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $104,013,000 | 3,900,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $102,345,960 | 3,324,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $89,326,160 | 3,412,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $78,499,200 | 3,120,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $66,688,000 | 3,200,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $52,440,000 | 2,208,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $53,970,000 | 3,000,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||